Mayne Pharma | MYX - EPS Earnings Per Share



Mayne Pharma reported AUD-0.89 in EPS Earnings Per Share for its fiscal semester ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025H2 Jun/2025 -0.89 Aug/28 2025
FY2025H1 Dec/2024 -46.30 Feb/25 2025
FY2024H2 Jun/2024 -27.10 -0.12 Aug/22 2024
FY2024H1 Dec/2023 -92.00 0.15 Feb/25 2024
FY2023H2 Jun/2023 -0.12 -0.57 -1.48 Aug/31 2023
FY2023H1 Dec/2022 0.15 -0.92 -0.32 Feb/28 2023
FY2022H2 Jun/2022 -1.48 -0.2 Aug/26 2022
FY2022H1 Dec/2021 -0.32 0.42 Feb/25 2022
FY2021H2 Jun/2021 -0.20 -0.50 -0.05 Aug/27 2021
FY2021H1 Dec/2020 0.42 -8.00 -0.01 Feb/24 2021
FY2015H1 Dec/2014 0.15 0.53 Feb/26 2015


Eps Change Date
Ansell USD 0.38 0.05 Dec/2024
Avita Medical USD -0.21 0.05 Dec/2024
Cochlear AUD 3.13 0.17 Dec/2024
CSL USD 4.27 2.44 Dec/2024
Healius AUD -0.02 0.03 Dec/2024
Integral Diagnostics AUD 0.04 0.01 Dec/2024
Medical Developments International AUD 0 0.34 Dec/2024
Nanosonics AUD 0.03 0.01 Dec/2024
Next Science -0.02 0 Dec/2024
Polynovo AUD 0.01 0 Jun/2025
Ramsay Health Care AUD 0.52 0.13 Dec/2025
ResMed USD 2.58 2.33 Jun/2025
Sigma Healthcare AUD 0 0.01 Jul/2024
Sonic Healthcare AUD 0.57 0.08 Jun/2025
Telix Pharmaceuticals AUD 0.28 0.22 Jun/2025